Wu, K., Guo, C., & Li, R. (2019). Clinical characterization of icotinib-induced chemoresistance in erlotinib-treated lung adenocarcinoma patient with EGFR mutations: A case report. Medicine (Baltimore).
Citación estilo ChicagoWu, Ka, Chao Guo, y Rong Li. "Clinical Characterization of Icotinib-induced Chemoresistance in Erlotinib-treated Lung Adenocarcinoma Patient With EGFR Mutations: A Case Report." Medicine (Baltimore) 2019.
Cita MLAWu, Ka, Chao Guo, y Rong Li. "Clinical Characterization of Icotinib-induced Chemoresistance in Erlotinib-treated Lung Adenocarcinoma Patient With EGFR Mutations: A Case Report." Medicine (Baltimore) 2019.
Precaución: Estas citas no son 100% exactas.